Parmax Pharma Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1002724,
    "name": "Parmax Pharma",
    "stock_name": "Parmax Pharma",
    "full_name": "Parmax Pharma Ltd",
    "name_url": "stocks-analysis/parmax-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "53.81",
    "chg": 2.56,
    "chgp": "5.0%",
    "dir": 1,
    "prev_price": "51.25",
    "mcapval": "20.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540359,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE240T01014",
    "curr_date": "Jun 10, 12:53 PM",
    "curr_time": "13:15 PM",
    "last_traded_at": "Jun 10, 12:53 PM IST",
    "bse_nse_vol": "875 ",
    "exc_status": "Active",
    "traded_date": "Jun 10, 2026",
    "traded_date_str": "2026 06 10",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/parmax-pharma-1002724-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Broad-Based Technical Strength Lifts Parmax Pharma Ltd to 52-Week High of Rs 53.81",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/parmax-pharma-ltd-hits-new-52-week-high-at-rs5381-4043708",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ParmaxPharmaLtd_priceRelatedfactors_4043708.png",
        "date": "2026-06-10 09:45:13",
        "description": "With a decisive 5% gap-up opening and a sustained rally to Rs 53.81, Parmax Pharma Ltd has surged to a fresh 52-week high, marking a 41.64% gain over the past year against a declining Sensex. This technical breakout underscores a strong momentum phase for the micro-cap pharmaceutical player."
      },
      {
        "title": "Parmax Pharma Q4 FY26: Mounting Losses Signal Deepening Crisis",
        "link": "https://www.marketsmojo.com/news/result-analysis/parmax-pharma-q4-fy26-mounting-losses-signal-deepening-crisis-4036066",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ParmaxPharma_quaterlyResult_4036066.png",
        "date": "2026-06-04 09:53:10",
        "description": "Parmax Pharma Ltd., a micro-cap pharmaceutical company specialising in Active Pharmaceutical Ingredients (API) and Contract Manufacturing Operations (CMO), reported a net loss of ₹0.58 crores for Q4 FY26 (Jan-Mar'26), marking the seventh consecutive quarter of losses. Whilst the loss narrowed sequentially from ₹0.73 crores in Q3 FY26, it remains significantly lower than the ₹1.49 crores loss in Q4 FY25. The company's shares surged 16.88% to ₹52.00 following the results, despite the troubling financial performance, suggesting speculative trading rather than fundamental improvement."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Parmax Pharma Ltd to 52-Week High of Rs 53.38",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/parmax-pharma-ltd-hits-new-52-week-high-of-rs5338-on-4-june-2026-4035643",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ParmaxPharmaLtd_priceRelatedfactors_4035643.png",
        "date": "2026-06-04 09:50:31",
        "description": "With a surge to Rs 53.38 on 4 Jun 2026, Parmax Pharma Ltd has reached a fresh 52-week high, propelled by a striking alignment of technical indicators and sustained price momentum that outpaces its sector and the broader market."
      },
      {
        "title": "When is the next results date for Parmax Pharma Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-parmax-pharma-ltd-4032576",
        "imagepath": "",
        "date": "2026-06-02 23:15:37",
        "description": "The next results date for Parmax Pharma Ltd is scheduled for June 2, 2026...."
      },
      {
        "title": "Are Parmax Pharma Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-parmax-pharma-ltd-latest-results-good-or-bad-4023956",
        "imagepath": "",
        "date": "2026-05-30 19:54:15",
        "description": "Parmax Pharma Ltd's latest financial results indicate significant operational distress. For the quarter ending December 2025, the company reported net sales of ₹2.53 crores, reflecting a year-on-year decline of 72.74% from ₹9.28 crores in the same quarter the previous year. This decline is indicative of severe challenges in maintaining customer contracts or market position. Although there was a sequential growth of 30.41% from the previous quarter, this improvement appears minimal and does not suggest a sustainable recovery.\n\nThe company incurred a net loss of ₹0.73 crores, which represents an 87.20% deterioration compared to the previous quarter's loss. The operating margin plummeted to -62.85%, a stark contrast to the positive margin of 2.16% reported in the same quarter last year. This drastic margin compression highlights fundamental operational challenges rather than temporary setbacks.\n\nParmax Pharma'..."
      },
      {
        "title": "Parmax Pharma Ltd Falls to 52-Week Low of Rs 22.6 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/parmax-pharma-ltd-stock-falls-to-52-week-low-of-rs226-3915864",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ParmaxPharmaLtd_priceRelatedfactors_3915864.png",
        "date": "2026-03-25 10:02:56",
        "description": ""
      },
      {
        "title": "Parmax Pharma Ltd Falls to 52-Week Low of Rs 24.5 Amidst Continued Weakness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/parmax-pharma-ltd-falls-to-52-week-low-of-rs-245-amidst-continued-weakness-3898506",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ParmaxPharmaLtd_priceRelatedfactors_3898506.png",
        "date": "2026-03-18 10:04:09",
        "description": "Parmax Pharma Ltd, a micro-cap entity in the Pharmaceuticals & Biotechnology sector, has declined sharply to a new 52-week low of Rs.24.5, marking a significant drop of 11.71% in today’s trading session. This fresh low underscores the stock’s ongoing underperformance relative to its sector and broader market indices."
      },
      {
        "title": "Parmax Pharma Ltd Falls to 52-Week Low of Rs 25 Amidst Weak Financials",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/parmax-pharma-ltd-falls-to-52-week-low-of-rs-25-amidst-weak-financials-3887189",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ParmaxPharmaLtd_priceRelatedfactors_3887189.png",
        "date": "2026-03-12 14:57:13",
        "description": "Parmax Pharma Ltd’s shares declined sharply to a new 52-week low of Rs.25 on 12 Mar 2026, marking a significant downturn amid ongoing financial headwinds and sector underperformance. The stock’s recent volatility and sustained downward trend reflect persistent challenges in the company’s financial metrics and market positioning."
      }
    ],
    "total": 121,
    "sid": "1002724",
    "stock_news_url": "https://www.marketsmojo.com/news/parmax-pharma-1002724"
  },
  "announcements": [
    {
      "caption": "Results-Delay in Financial Results",
      "datetime": "03-Jun-2026",
      "details": "Results for Financial Results for Quarter and Financial Year ended March 31 2026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
      "datetime": "03-Jun-2026",
      "details": "Reschedule of Boar Meeting and Outcome of Board Meeting",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Fund Raising",
      "datetime": "03-Jun-2026",
      "details": "Parmax Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/06/2026 inter alia to consider and approve Fund raising",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Broad-Based Technical Strength Lifts Parmax Pharma Ltd to 52-Week High of Rs 53.81

2026-06-10 09:45:13

With a decisive 5% gap-up opening and a sustained rally to Rs 53.81, Parmax Pharma Ltd has surged to a fresh 52-week high, marking a 41.64% gain over the past year against a declining Sensex. This technical breakout underscores a strong momentum phase for the micro-cap pharmaceutical player.

Read full news article

Parmax Pharma Q4 FY26: Mounting Losses Signal Deepening Crisis

2026-06-04 09:53:10

Parmax Pharma Ltd., a micro-cap pharmaceutical company specialising in Active Pharmaceutical Ingredients (API) and Contract Manufacturing Operations (CMO), reported a net loss of ₹0.58 crores for Q4 FY26 (Jan-Mar'26), marking the seventh consecutive quarter of losses. Whilst the loss narrowed sequentially from ₹0.73 crores in Q3 FY26, it remains significantly lower than the ₹1.49 crores loss in Q4 FY25. The company's shares surged 16.88% to ₹52.00 following the results, despite the troubling financial performance, suggesting speculative trading rather than fundamental improvement.

Read full news article

Broad-Based Technical Strength Lifts Parmax Pharma Ltd to 52-Week High of Rs 53.38

2026-06-04 09:50:31

With a surge to Rs 53.38 on 4 Jun 2026, Parmax Pharma Ltd has reached a fresh 52-week high, propelled by a striking alignment of technical indicators and sustained price momentum that outpaces its sector and the broader market.

Read full news article

When is the next results date for Parmax Pharma Ltd?

2026-06-02 23:15:37

The next results date for Parmax Pharma Ltd is scheduled for June 2, 2026....

Read full news article

Are Parmax Pharma Ltd latest results good or bad?

2026-05-30 19:54:15

Parmax Pharma Ltd's latest financial results indicate significant operational distress. For the quarter ending December 2025, the company reported net sales of ₹2.53 crores, reflecting a year-on-year decline of 72.74% from ₹9.28 crores in the same quarter the previous year. This decline is indicative of severe challenges in maintaining customer contracts or market position. Although there was a sequential growth of 30.41% from the previous quarter, this improvement appears minimal and does not suggest a sustainable recovery. The company incurred a net loss of ₹0.73 crores, which represents an 87.20% deterioration compared to the previous quarter's loss. The operating margin plummeted to -62.85%, a stark contrast to the positive margin of 2.16% reported in the same quarter last year. This drastic margin compression highlights fundamental operational challenges rather than temporary setbacks. Parmax Pharma'...

Read full news article

Parmax Pharma Ltd Falls to 52-Week Low of Rs 22.6 as Sell-Off Deepens

2026-03-25 10:02:56

Read full news article

Parmax Pharma Ltd Falls to 52-Week Low of Rs 24.5 Amidst Continued Weakness

2026-03-18 10:04:09

Parmax Pharma Ltd, a micro-cap entity in the Pharmaceuticals & Biotechnology sector, has declined sharply to a new 52-week low of Rs.24.5, marking a significant drop of 11.71% in today’s trading session. This fresh low underscores the stock’s ongoing underperformance relative to its sector and broader market indices.

Read full news article

Parmax Pharma Ltd Falls to 52-Week Low of Rs 25 Amidst Weak Financials

2026-03-12 14:57:13

Parmax Pharma Ltd’s shares declined sharply to a new 52-week low of Rs.25 on 12 Mar 2026, marking a significant downturn amid ongoing financial headwinds and sector underperformance. The stock’s recent volatility and sustained downward trend reflect persistent challenges in the company’s financial metrics and market positioning.

Read full news article

View All News